Laser
Retinal laser therapy, reinvented
Fully integrated yellow laser combining Quantel Medical exclusive fiber laser technology with single spot, multispot and subliminal treatment modes.
Easyret features a unique clinically oriented user interface and software-guided treatment procedures facilitating the implementation of the laser spots and enhancing retinal treatments.
Key features:
- Most versatile wavelength with best chromophore absorption profile.
- Perfectly homogenous laser spot profile ensuring even laser treatments.
- MultiSpot mode for peripheral treatments better tolerated by patients.
- SubLiminal subthreshold mode for tissue sparing macular treatments.
Fiber laser technology
A world first to market in photocoagulation: Fiber Laser Cavity
Stemming from the ELBATM technology, developed and successfully marketed by Quantel laser for various applications, this new generation of laser cavity provides unique advantages:
- The emission of pure 577nm yellow wavelength
- An excellent beam quality ensuring a homogeneous laser spot profile (top hat)
- An extended lifetime thanks to a simple, compact and reliable technology
Proprietary 577nm SubLiminal emission mode
In addition to SingleSpot and MultiSpot delivery modes, Easyret features the SubLiminal technology.
The use of this subthreshold treatment mode converts each laser shot into a “pulse envelope” composed of a customizable train of short pulses, allowing the operator to fully adjust the pulse duration (On Time) and interval (Off Time). This fined-tuned control of the laser treatment settings ensures a precise management of the thermal effect on the targeted tissues.
Enhanced software interface
Easyret provides an intuitive and versatile software user interface simplifying the use of the Single Spot, MultiSpot and SubLiminal treatment modes. Built in a clinically oriented manner, Easyret offers 3 different types of visible targets (aiming beam) facilitating the implementation of the laser spots with each treatment mode.
Fully integrated design
Easyret offers a fully integrated design in which the laser and the slit lamp are optimally integrated integrated for better ergonomics and ease of use. It is available with two types of slit lamps to adapt to the operator’s working habits. Both versions feature:
- an integrated laser adapter featuring a continuously variable parfocal zoom
- a large touch screen interface to monitor the treatment settings
- a click wheel to control the patterns settings
- an intelligent footswitch to control the laser settings
Yellow laser wavelength
Presented as the most versatile wavelength in the scientific literature, the 577nm wavelength offers the following benefits:
- Excellent combined absorption by both melanin and oxyhemoglobin (peak absorption of oxyhemoglobin) [1,2]
- Very little absorption by macular xanthophyll pigments [1,2]
- Excellent penetration through cataracts and hazy media [1,2]
Subliminal treatment mode
Composed of a train of extremely short microsecond pulses, this subthreshold treatment mode (non-visible laser impacts) is a tissue sparing treatment mode avoiding scarring [7,8] while treating Diabetic Macular Edema [7] and Central Serous Chorioretinopathy [8].
The SubLiminal treatment mode can be delivered through 3 customizable patterns for better adaptation to the treatment site.
Multispot treatment mode
Characterized by the use of short pulse durations from 10 to 20 ms, the MultiSpot treatment mode offers many advantages over classical treatments:
- Less heat diffusion to the retina and choroid, less damage to the retinal nerve fiber layer [3,4]
- Comfortable treatment better tolerated by patients [5]
- Treatment time reduction (full PRP in 1 session) [6]
The MultiSpot treatment mode can be delivered through 4 customizable patterns for better adaptation to the treatment site.
Single spot - Squares - Circles - Triple arcs
User guide
User guide SubLiminal
User guide MultiSpot
User guide SingleSpot
Symposium
EURETINA 2019 - SubLiminal laser for cCSC management
EURETINA 2019 - Fovea-Involving DME: Reasons for the subliminal approach
EURETINA 2019 - Yellow subthreshold laser vs pdt in eyes with CCSC
EURETINA 2019 - Expanding clinical application of SubLiminal laser
EURETINA 2019 - New generation lasers: what are the differences?
PAAO 2019 - Tratamiento laser Subliminal para enfermedades maculares
PAAO 2019 - Como optimizar el tratamiento laser en el 2019
Mosar
Laser indirect ophthalmoscope (Keeler Vantage Plus)
GentleFoot Footswitch
Click Wheel
Model still available in some countries according to local registration: Supra Scan
For further information, please contact us.
Clinical References
1- Vogel M, Schäfer FP, Stuke M, Müller K, Theuring S, Morawietz A. Animal, experiments for the determination of an optimal wavelength for retinal coagulations. Graefes Arch Clin Exp Ophthalmol. 1989;227:277-280.2- Mainster MA. Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems. Ophthalmology.1986;93:952-958.
3- Jain A, Blumenkranz MS, Paulus Y et al. Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol. 2008; 126:78-85.
4- Yi-Ryeung Park, Donghyun Jee. Changes in Peripapillary Retinal Nerve Fiber Layer Thickness after Pattern Scanning Laser Photocoagulation in Patients with Diabetic Retinopathy. Korean J Ophthalmol 2014;28(3):220-225.
5- Hussainy S Al, Dodson PM and Gibson JM. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye (2008) 22, 96–99
6- Muqit MM, Marcellino GR, Henson DB et al. Single-Session vs Multiple-Session Pattern Scanning Laser Panretinal Photocoagulation in Proliferative Diabetic. Arch ophthalmol, 2010, 128 : 525-533
7- Yoon Hyung Kwon, Dong Kyu Lee, Oh Woong Kwon. The short-term efficacy of subthreshold micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema. Korean J Ophthalmol 2014;28(5):379-385
8- Scholz P, Ersoy L, Boon CJF, Fauser S. Subthreshold Micropulse Laser (577 nm). Treatment in Chronic Central Serous Chorioretinopathy. Ophthalmologica 2015 DOI: 10.1159/000439600